[Present-day aminoglycosides in the treatment of suppurative-septic diseases]. 1985

A N Lobuseva, and V P Pozdniakova, and A A Firson, and I I Kolker, and P S Navashin

The therapeutic efficacy, tolerance and pharmacokinetics of sisomicin, gentamicin and a new dosage form of kanamycin sulfate as an ampoule solution for intravenous injection were studied clinically. High therapeutic efficacy of the above three aminoglycosides in the treatment of severe inflammatory infections caused by gram-negative bacteria was shown with the use of the adequate doses. Favourable results of the therapy estimated by the laboratory and clinical data were observed in 81-90 per cent of the patients.

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004755 Enterobacteriaceae A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock. Coliform Bacilli,Enterobacteria,Ewingella,Leclercia,Paracolobactrum,Sodalis
D005839 Gentamicins A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS. Gentamicin Sulfate (USP),Gentamycin,G-Myticin,Garamycin,Gentacycol,Gentamicin,Gentamicin Sulfate,Gentamycins,Gentavet,Genticin,G Myticin,GMyticin,Sulfate, Gentamicin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside

Related Publications

A N Lobuseva, and V P Pozdniakova, and A A Firson, and I I Kolker, and P S Navashin
March 1965, Khirurgiia,
A N Lobuseva, and V P Pozdniakova, and A A Firson, and I I Kolker, and P S Navashin
April 1978, Akusherstvo i ginekologiia,
A N Lobuseva, and V P Pozdniakova, and A A Firson, and I I Kolker, and P S Navashin
January 1993, Vestnik khirurgii imeni I. I. Grekova,
A N Lobuseva, and V P Pozdniakova, and A A Firson, and I I Kolker, and P S Navashin
January 1994, Klinicheskaia khirurgiia,
A N Lobuseva, and V P Pozdniakova, and A A Firson, and I I Kolker, and P S Navashin
July 1955, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
A N Lobuseva, and V P Pozdniakova, and A A Firson, and I I Kolker, and P S Navashin
August 1960, Casopis lekaru ceskych,
A N Lobuseva, and V P Pozdniakova, and A A Firson, and I I Kolker, and P S Navashin
October 1985, Vestnik khirurgii imeni I. I. Grekova,
A N Lobuseva, and V P Pozdniakova, and A A Firson, and I I Kolker, and P S Navashin
January 1985, Klinicheskaia khirurgiia,
A N Lobuseva, and V P Pozdniakova, and A A Firson, and I I Kolker, and P S Navashin
January 1951, Revue medicale du Moyen-Orient,
A N Lobuseva, and V P Pozdniakova, and A A Firson, and I I Kolker, and P S Navashin
April 1990, Vestnik khirurgii imeni I. I. Grekova,
Copied contents to your clipboard!